MedTrace Logo

Coach2Move: Sustainable in Daily Practice

NCT03212859 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 292

Last updated 2021-03-17

No results posted yet for this study

Summary

Implementation of a previously shown (cost-)effective physical therapeutic treatment strategy for community-dwelling older adults.

Conditions

  • Sedentary Lifestyle
  • Physical Activity
  • Frail Elderly Syndrome

Interventions

BEHAVIORAL

Coach2Move

Coach2Move is a multicomponent physiotherapeutic approach in addition to usual care physiotherapy consisting of: * Extensive intake during which not only impairments and disabilities, but wishes, barriers and facilitators considering physical functioning are profoundly examined. * Motivational interviewing is used to find and deal with barriers for becoming physically active and shared-decision making in goal setting. * The approach is patient focused (tailor made) and goal-oriented: the physiotherapist coaches the patient and the environment in reaching and maintaining their own goals. * In consultation with the patient, a stratified intervention is chosen by picking the best fitting option out of three patient-tailored intervention profiles with a predefined number of intervention sessions.

BEHAVIORAL

Usual Care

Usual care physiotherapy among older adults: * Intake of 30 minutes consisting of examining medical history, physical functioning and functional exercises to assess the demand for care. * Use of treatment modalities to enhance physical functioning (strength, mobility, coordination, balance etc.) * Consultation and advisory role in relation to the functional status of geriatric patients and his/her relations. * Collaborate with other disciplines in a multidisciplinary context.

Sponsors & Collaborators

  • ZonMw: The Netherlands Organisation for Health Research and Development

    collaborator OTHER

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Ward Heij, MSc · Radboud University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-06
Primary Completion
2020-09-04
Completion
2020-09-04

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03212859 on ClinicalTrials.gov